Enteral Feeding Devices Market

The global enteral feeding devices market is projected to reach 5.6 billion in 2029 from USD 4.0 billion in 2023, at a CAGR of 6.2% between 2023 and 2029. The rising technological advancemnets and increasing geriatric population is driving the growth of the market. The As the global population ages, the number of individuals requiring enteral feeding is expected to rise.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035

Elderly patients often experience age-related decline in appetite or swallowing difficulties, making enteral feeding a vital support system.

Based on type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, administration sets, enteral syringes and consumables. The enteral feeding tubes accounts for the largest share in the enteral feeding devices market, Enteral feeding tubes are a crucial component of enteral feeding devices. They act as a conduit to deliver liquid nutrition directly into a patient’s stomach or small intestine, bypassing the mouth and esophagus. Enteral feeding tubes are essential components of enteral feeding devices, providing a safe and reliable way to deliver essential nutrients to patients who cannot consume food orally which is expected to drive the segment growth.

Based on application, the enteral feeding devices market is segmented into oncology, gastrointestinal diseases, nuerological diseases, diabetes, hypermetabolism and other applications. The oncology accounts for the largest share in the enteral feeding devices market, cancer and its treatment (surgery, radiation, chemotherapy) can significantly impact a patient’s appetite and ability to absorb nutrients. Enteral feeding ensures they receive the necessary calories, proteins, vitamins, and minerals to support their immune system, fight infection, and promote healing which is expected to drive the market growth.

In 2023, North America accounted for the largest share of the enteral feeding devices market, followed by Europe and Asia Pacific. The United States and Canada have well-equipped hospitals and a strong focus on advanced medical care, which supports the adoption of enteral feeding devices, also compared to established markets like North America and Europe, the Asia Pacific region often offers lower labor costs, making it an attractive option for companies seeking to optimize manufacturing expenses.

Additionally, several countries in the region, like China and India, have developed a robust infrastructure for manufacturing pharmaceuticals and medical devices which is expected to lead to Asia Pacific growing at the fastest rate during the forecast period.

The major players in the enteral feeding devices market include include The prominent players in the medical device contract manufacturing market include Fresenius SE & Co. KGAA (Germany), Cardinal Health, Inc. (US), Nestlé S.A. (Switzerland), Avanos Medical, Inc. (US), Danone S.A. (France), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Moog Inc. (US), Boston Scientific Corporation (US), Baxter International Inc. (US), Vygon (France), and Other players in the enteral feeding devices market are Applied Medical Technology (US), Amsino International Inc. (US), Omex Medical Technology (India), Danumed Medizintechnik (Germany), Medline Industries, Inc. (US), Fuji Systems (Japan), Kentec Medical (US), Dynarex Corporation (US), Vesco Medical LLC (US), Medela AG (Switzerland), Alcor Scientific (US), and Romsons (India)

Recent Developments of Enteral Feeding Devices Industry:

In September 2022, Cardinal Health, Inc. (US) announced the partnership with Kinaxis (Canada) to enhance the Kinaxis RapidResponse Platform used for supply chain agility and medical product visibility.

In November 2022, Boston Scientific signed an agreement for the acquisition of Apollo Endosurgery, Inc.,. This agreement includes devices, which are used during endoluminal surgery (ELS) procedures, to close gastrointestinal defects, manage gastrointestinal complications, and aid in weight loss for patients suffering from obesity.

In March 2021, Applied Medical Technology, Inc. (US) launched its gastric-jejunal enteral feeding tube family (G-JETs) to include the low-profile micro-G-JET to link up the enteral nutrition needs of pediatric patients.

In March 2022, Vygon Group (France) announced the acquisition of distributor Macatt Medica (Peru). The acquisition is expected to grow the presence of Vygon Group (France), in the South American region, specifically for its broad range of enteral feeding products.

The global enteral feeding devices market is experiencing remarkable growth, fueled by the increasing prevalence of chronic diseases and the aging population. Valued at $4.0 billion in 2023, this market is projected to reach $5.6 billion by 2029, growing at a robust compound annual growth rate (CAGR) of 6.2%.

Enteral feeding devices play a crucial role in delivering essential nutrients directly into the digestive system, offering a lifeline to patients who cannot consume food orally due to various medical conditions. As the world’s population ages and the incidence of chronic illnesses rises, the demand for these devices is soaring.

Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035

Driving Forces Behind the Growth

The rapid growth of the geriatric population and the accompanying rise in age-related chronic diseases are the primary drivers of this market’s expansion. With advances in healthcare and improved living standards, people are living longer, but they also face an increased risk of conditions that can impair their ability to swallow or maintain a healthy appetite.

Enteral feeding devices provide a reliable solution for delivering essential nutrients, preventing malnutrition, and promoting overall health in elderly patients. Additionally, the growing awareness among healthcare professionals and the public about the benefits of enteral feeding is contributing to its wider adoption.

Opportunities and Challenges

The market is rife with opportunities, particularly in the home care sector. Improvements in enteral feeding devices, such as quieter pumps, disposable feeding sets, and remote monitoring capabilities, have made them more user-friendly and portable for home use. As healthcare systems shift towards home-based care models, enteral feeding devices enable patients to receive essential nutrition in the comfort of their own homes, creating significant growth opportunities.

However, the market also faces challenges. The dearth of skilled professionals and endoscopy specialists trained in the proper placement, management, and monitoring of enteral feeding devices can create bottlenecks, potentially hindering market growth.

Competitive Landscape and Industry Ecosystem

The enteral feeding devices market is highly competitive, with new players entering and established companies vying for market share. This competition drives down prices as businesses strive to maintain profitability while keeping their offerings affordable. Consolidation within the enteral nutrition industry, particularly the rise of home care settings, creates larger entities with greater purchasing power, further pressuring smaller players.

Key players in the market include Fresenius SE & Co. KGAA, Cardinal Health, Inc., Nestlé S.A., Avanos Medical, Inc., Danone S.A., Becton, Dickinson and Company, B. Braun Melsungen AG, CONMED Corporation, Cook Medical, Moog Inc., Boston Scientific Corporation, Baxter International Inc., Vygon, and others.

Looking Ahead

As the world’s population continues to age and chronic diseases become more prevalent, the demand for enteral feeding devices is expected to surge. With ongoing advancements in technology and a growing emphasis on home-based care, this market is poised to play an increasingly vital role in delivering essential nutrition and improving the quality of life for patients worldwide.

Enteral Feeding Devices Market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 6.9% from 2022 to 2027.

Surging growth in the elderly population; rising healthcare costs; rising prevalence of chronic diseases such as cancer, gastrointestinal diseases, diabetes, and neurological disorders; high number of preterm births and genetic disorders among pediatrics and neonatal populations; rising awareness towards nutritional therapies; and growing improvements in healthcare facilities across emerging countries are driving the growth of the enteral feeding devices market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035

The key players operating in the enteral feeding devices market include Nestlé S.A. (Switzerland), Fresenius Kabi (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), B. Braun Melsungen AG (Germany), and Becton, Dickinson and Company (US).

By type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables. Administration sets is expected to show fastest growth during the forecast period. The increasing focus on patient care and product safety has led to the introduction of ENFit Connectors as per the new standards to help reduce the risk of misconnections and safety issues. This, in addition to the growth in the number of patients seeking enteral nutrition across the globe, has spurred the demand for administration sets globally.

Based on age group, the enteral feeding devices market is segmented into adult patients (18 years and above) and pediatric patients (that includes neonates, infants, and children between 2-12 years of age, and adolescents between 12-16 years of age). Pediatric patients segment is expected to show fastest growth rate during the forecast period. Increasing cases of preterm births and genetic disorders among pediatric patients is driving the rapid growth in demand for providing enteral nutrition therapy in pediatric age group segment. Additionally, a growing number of pediatric patients have been diagnosed with conditions often associated with adults in the past, such as diabetes, obesity, and cancer. The increasing prevalence of such diseases among pediatric patients has further increased the demand for medications and nutritional feed delivery systems tailored for this segment.

In 2020, the oncology segment accounted for the largest share of the enteral feeding devices market, followed by gastrointestinal diseases, neurological disorders diabetes, hypermetabolism, and other applications. The oncology segment will continue to dominate the market by 2026, growing at a CAGR during the forecast period. The increase in the prevalence of various types of cancers—especially head & neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer—is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients

Enteral feeding devices market by end user includes Hospitals, home care settings, and ambulatory care settings. The home care settings segment is expected to show fastest growth rate during the forecast period. Home enteral nutrition (HEN) is used in patients with a functional gastrointestinal (GI) tract and who can receive therapy outside an acute care setting. Due to the increasing pressure on hospitals to curtail the soaring healthcare costs and the COVID-19 outbreak, there has been a shift from extended hospital treatment towards treatment at home. As a result, the demand for home based nutritional care is increasing, which is expected to drive a rapid growth in the home care settings segment through 2027.

By Region, the enteral feeding devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to show the highest growth rate during the forecast period. Several factors such as rising geriatric population, increased awareness of and accessibility to advanced healthcare facilities, rising healthcare spending, growing focus of key market players on the emerging Asia Pacific countries, and rapid improvements in the health insurance sector are driving the growth of the Asia Pacific enteral feeding devices market

Enteral Feeding Devices Market Dynamics:

Drivers:

Shift from parenteral to enteral nutrition for patients
High incidence of preterm births and genetic disorders in pediatric and neonatal patients
Growing demand for enteral feeding in home care sector
Rapid growth in geriatric population and age-related chronic diseases
Increasing prevalence of dysphagia

Restraints:

Complications associated with enteral feeding devices

Opportunities:

High growth opportunities for market players in developing countries

Challenges:

Insufficient reimbursement policies for enteral nutrition therapy in developing countries
Dearth of skilled professionals and endoscopy specialists

Enteral Feeding Devices Market in terms of revenue was estimated to be worth $3.7 billion in 2022 and is poised to reach $5.2 billion by 2027, growing at a CAGR of 6.9% from 2022 to 2027.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035

Enteral Feeding Devices Industry Key Market Players:

The administration sets is expected to show fastest growth during the forecast period

Pediatric segment in age group segment is expected to show the fastest growth during the forecast period

Based on age group, the enteral feeding devices market is segmented into adult patients (18 years and above) and pediatric patients (that includes neonates, infants, and children between 2–12 years of age, and adolescents between 12–16 years of age). Pediatric patients segment is expected to show fastest growth rate during the forecast period. Increasing cases of preterm births and genetic disorders among pediatric patients is driving the rapid growth in demand for providing enteral nutrition therapy in pediatric age group segment. Additionally, a growing number of pediatric patients have been diagnosed with conditions often associated with adults in the past, such as diabetes, obesity, and cancer. The increasing prevalence of such diseases among pediatric patients has further increased the demand for medications and nutritional feed delivery systems tailored for this segment.

Oncology segment is expected to account for the largest share in the enteral feeding devices market

In 2020, the oncology segment accounted for the largest share of the enteral feeding devices market, followed by gastrointestinal diseases, neurological disorders diabetes, hypermetabolism, and other applications. The oncology segment will continue to dominate the market by 2026, growing at a CAGR during the forecast period. The increase in the prevalence of various types of cancers — especially head & neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer — is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients

Home care settings segment to show fastest growth rate in end user segment through 2027

Asia Pacific to witness the highest growth rate during the forecast period